NFINITY
Dead / Abandoned — Abandoned — no statement of use filed (as of 19 Jan 2026)
What this means for you
This application is over — abandoned 19 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97643112
- Mark type
- Stylized text
- Filed
- 21 Oct 2022
- Published for opposition
- 23 Apr 2024
- Abandoned
- 19 Jan 2026
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic cell preparations based on NK cells (natural killer cells) for the treatment of cancer, infectious diseases, and immune disorders, excluding pharmaceutical preparations or use in pharmaceutical preparations; bio-engineered component for a therapeutic material, namely, cell lines based on NK cells (natural killer cells) used for medical or clinical use used for immunotherapy, excluding pharmaceutical preparations or use in pharmaceutical preparations
Owner
- Fate Therapeutics, Inc., San Diego, CA, US
- Fate Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 19 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 19 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2025 — SOU EXTENSION 2 GRANTED
- 17 Jun 2025 — SOU EXTENSION 2 FILED
- 17 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Oct 2024 — SOU EXTENSION 1 GRANTED
- 02 Oct 2024 — SOU EXTENSION 1 FILED
- 02 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION
- 03 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER